文献速递运动医学关节外科

系统性炎症性疾病患者前交叉韧带重建术后进展至全膝关节置换术的比率与时机:一项长期倾向匹配队列研究

Rate and Timing of Progression to Total Knee Arthroplasty After Anterior Cruciate Ligament Reconstruction in Patients With Systemic Inflammatory Disease: A Long-term Propensity-Matched Cohort Study.
PubMed 文献 · Am J Sports Med · 2025-01-24

该回顾性倾向匹配队列研究比较了合并慢性炎症性系统疾病(CID)与无CID患者在前交叉韧带重建(ACLR)术后的结局。CID组关节纤维化、骨关节炎和全膝关节置换术(TKA)发生率更高,且TKA发生更早,但多数患者报告结局指标并未更差。

要点

  • CID组关节纤维化率16.7% vs 非CID组4.3%(P=.031),骨关节炎率33.3% vs 16.7%(P=.041)。
  • CID组TKA率16.7% vs 非CID组3.3%(P=.016),TKA发生时间14.7 vs 23.5年(P=.032)。
  • CID组TKA风险比为3.94(95%CI 1.05-14.8;P=.042),25年无TKA生存率64.9% vs 91.2%(P=.029)。

核心结论

  • CID增加ACLR术后关节纤维化、骨关节炎和TKA的发生率,且CID患者接受TKA的时间显著更早。
  • 值得注意的是,CID患者的大多数患者报告结局指标并未更差,因此ACLR重建结构本身在CID患者中未必更差。
  • 尽管如此,这些患者在ACLR术后临床前景方面需要被谨慎告知。

研究设计与样本

  • 研究为回顾性队列研究,证据等级3级。
  • 对1990年至2021年期间因创伤性前交叉韧带断裂接受ACLR的所有患者进行区域数据集回顾性查询。
  • 识别所有合并CID的患者,并将其与无CID对照进行倾向匹配。
  • 共识别30例接受ACLR并诊断为CID的患者,倾向匹配至120例无CID对照。

主要发现

  • CID组与非CID组随访时间相似(均值14.6 vs 14.2年;P=.868)。
  • CID组关节纤维化率16.7% vs 非CID组4.3%(P=.031),骨关节炎率33.3% vs 16.7%(P=.041)。
  • CID组TKA率16.7% vs 非CID组3.3%(P=.016),TKA发生时间14.7 vs 23.5年(P=.032)。
  • CID组视觉模拟量表疼痛评分更高(均值2.00 vs 1.20;P=.043),但满意度略高(均值3.92 vs 3.39;P=.043)。
  • 单变量Cox回归模型中,CID组再撕裂风险比为1.43(95%CI 0.46-4.51;P=.537);25年无再撕裂生存率85.7% vs 87.3%(P=.53)。

关键数值与推荐

  • CID组TKA风险比为3.94(95%CI 1.05-14.8;P=.042)。
  • Kaplan-Meier生存分析显示CID组25年无TKA生存率显著降低(64.9% vs 91.2%;P=.029)。
  • 膝关节活动度、感染率、再撕裂率、再撕裂时间及骨关节炎发生时间在两组间无统计学差异。
  • 损伤前Tegner评分、术后Tegner评分、Tegner评分变化及IKDC评分无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anterior cruciate ligament reconstruction (ACLR) is one of the most common orthopaedic procedures and one of the most well studied. Despite extensive research dedicated to ACLR, there is limited understanding of how chronic inflammatory systemic diseases (CIDs) such as rheumatoid arthritis and systemic lupus erythematosus affect outcomes. PURPOSE: To compare the outcomes of ACLR in cohorts of patients with and without CID. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A retrospective query of a regional data set was conducted for all patients who underwent ACLR from 1990 to 2021 for traumatic ACL rupture. All patients with CID were identified and propensity matched to non-CID controls. Baseline characteristics and clinical outcomes were identified through retrospective chart review, and patients were contacted for subjective outcomes. RESULTS: A total of 30 patients with ACLR and a diagnosis of CID were identified. These patients were propensity matched to 120 non-CID controls. Baseline demographic and surgical characteristics demonstrated no statistical differences. Follow-up duration was similar between the CID and non-CID groups (mean, 14.6 vs 14.2 years; P = .868). The CID cohort had a higher arthrofibrosis rate (16.7% vs 4.3%; P = .031), higher osteoarthritis rate (33.3% vs 16.7%; P = .041), higher total knee arthroplasty (TKA) rate (16.7% vs 3.3%; P = .016), and earlier time to TKA (14.7 vs 23.5 years; P = .032). Knee range of motion, infection rate, retear rate, time to retear, and time to osteoarthritis were not statistically different between the cohorts. The CID cohort had higher visual analog scale pain scores (mean, 2.00 vs 1.20; P = .043) but slightly higher satisfaction (mean, 3.92 vs 3.39; P = .043). There were no differences in preinjury Tegner, postoperative Tegner, change in Tegner, or IKDC score. In a univariate Cox regression model, the CID cohort had a retear hazard ratio of 1.43 (95% CI, 0.46-4.51; P = .537). Kaplan-Meier survival revealed no significant differences in retear-free survival between the CID and non-CID cohorts at 25 years (85.7% vs 87.3%; P = .53). The CID cohort had a TKA hazard ratio of 3.94 (95% CI, 1.05-14.8; P = .042). Kaplan-Meier survival demonstrated significantly decreased TKA-free survival at 25 years in the CID cohort (64.9% vs 91.2%; P = .029). CONCLUSION: CID increases the incidence of arthrofibrosis, osteoarthritis, and TKA in those undergoing ACLR. Patients with CID also undergo TKA significantly sooner than non-CID counterparts. Notably, the majority of patient-reported outcome measures are no worse in patients who have a CID diagnosis. Thus, ACLR constructs themselves may not necessarily fare worse in patients with CID. Nonetheless, these patients need to be cautiously counseled on the clinical outlook after their ACLR.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Pan X, Wang AS, Johnson QJ, et al. Rate and Timing of Progression to Total Knee Arthroplasty After Anterior Cruciate Ligament Reconstruction in Patients With Systemic Inflammatory Disease: A Long-term Propensity-Matched Cohort Study. Am J Sports Med. 2025. PMID: 39850013. doi:10.1177/03635465241310520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。